semaglutide cardiovascular outcomes news 🔴Cardiovascular with by severity of chronic kidney disease in type 2 diabetes: the FLOW trial⤵️ 🔹Semaglutide significantly reduced the risk of CV death/MI/stroke regardless of baseline CKD severity in participants semaglutide cardiovascular outcomes study news

This will make some people feel like they may have just made a mistake in reading the weighing scale

I dont think theres enough data

Since the GLP-1 hormone acts directly on the stomach muscles by reducing the rate of gastric contractions, Wegovys amplified dose has caused individuals to experience a pronounced slowing of gastric emptying, which has caused severe gastroparesis side effects

Among the businesses surveyed by WTW this year, 30% said theyre at least somewhat likely to remove coverage in the next few years if prices remain where they are, with only 15% of those without coverage considering adding it at current prices